| Issue |
Med Sci (Paris)
Volume 34, October 2018
Cancer biomarkers
|
|
|---|---|---|
| Page(s) | 81 - 86 | |
| DOI | https://doi.org/10.1051/medsci/201834f114 | |
| Published online | 07 November 2018 | |
Overexpression of RBM10 induces osteosarcoma cell apoptosis and inhibits cell proliferation and migration
Department of Orthopaedics, Zaozhuang Municipal Hospital, 41 Longtou Rd, Zaozhuang 277100, Shandong, P.R. China
* Corresponding author hanslzz@163.com
Osteosarcoma is the most common malignant bone tumor with high incidence in adolescence and poor prognosis. RBM10, a member of RBPs, was reported to be a tumor suppressor in many kinds of cancers. However, the roles of RBM10 in osteosarcoma remain unknown. In this study, we found that overexpression of RBM10 decreased osteosarcoma cell proliferation and colony formation in soft agar, and inhibited osteosarcoma cell migration and invasion. Our results also revealed that RBM10 overexpression induced osteosarcoma cell apoptosis via the inhibition of Bcl-2, the activation of caspase-3, and the transcription and production of TNF-α. Our results indicated that RBM10 acts as a tumor suppressor in osteosarcoma. This could enable to define a new strategy for diagnosis and treatment of patients with osteosarcoma.
Key words: osteosarcoma / RBM10 / tumor suppressor / cell proliferation / cell apoptosis
© 2018 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.